SBC Medical Group Holdings Incorporated
SBC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Market Cap | $537 | $1,088 | $1,028 |
| - Cash | $125 | $103 | $52 |
| + Debt | $12 | $23 | $16 |
| Enterprise Value | $424 | $1,008 | $992 |
| Revenue | $205 | $194 | $174 |
| % Growth | 6.1% | 11.1% | – |
| Gross Profit | $156 | $137 | $115 |
| % Margin | 76% | 70.9% | 65.9% |
| EBITDA | $77 | $86 | $30 |
| % Margin | 37.6% | 44.4% | 17% |
| Net Income | $47 | $39 | $6 |
| % Margin | 22.7% | 20.3% | 3.6% |
| EPS Diluted | 0.483 | 0.418 | 0.037 |
| % Growth | 15.5% | 1,039% | – |
| Operating Cash Flow | $21 | $51 | -$0 |
| Capital Expenditures | -$3 | -$11 | -$25 |
| Free Cash Flow | $17 | $39 | -$25 |